Clinical and Molecular Characteristics of Neuronal Ceroid Lipofuscinosis in Saudi Arabia
Authors:
- 7 March 2024
- journal article
- research article
- Published by Elsevier in Pediatric Neurology
- Vol. 155, 149-155
Abstract
No abstract availableKeywords
Funding Information
- King Fahad Medical City
This publication has 33 references indexed in Scilit:
- Neuronal ceroid lipofuscinosis: genetic and phenotypic spectrum of 14 patients from TurkeyNeurological Sciences, 2021
- Neuronal Ceroid Lipofuscinosis: Potential for Targeted TherapyDrugs, 2020
- Rapid progression of a walking disability in a 5-year-old boy with a CLN6 mutationBrain and Development, 2019
- Late-onset childhood neuronal ceroid lipofuscinosis: Early clinical and electroencephalographic markersEpilepsy Research, 2018
- Genetics of the neuronal ceroid lipofuscinoses (Batten disease)Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2015
- NCL diseases — clinical perspectivesBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2013
- The neuronal ceroid-lipofuscinoses: A historical introductionBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2013
- Kufs Disease, the Major Adult Form of Neuronal Ceroid Lipofuscinosis, Caused by Mutations in CLN6The American Journal of Human Genetics, 2011
- Variant Late Infantile Neuronal Ceroid Lipofuscinosis (CLN6 Gene) in Saudi ArabiaPediatric Neurology, 2009
- Variability in the clinical and pathological findings in the neuronal ceroid lipofuscinoses: Review of data and observationsAmerican Journal of Medical Genetics, 1992